Results 141 to 150 of about 184,535 (247)
A Reactive Synchronized Motion Controller for Dual-Arm Cooperation with Closed-Chain Constraints. [PDF]
Ju F, Wang Z, Ge M, Jin H, Zhao J.
europepmc +1 more source
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Improving iSpyMacCas9 multiplex genome editing in rice by CRISPR-combo-mediated BBM1 activation. [PDF]
Byiringiro I +5 more
europepmc +1 more source
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +16 more
wiley +1 more source
Efficient Binding Affinity Estimation for Fragment-Based Compounds Using a Separated Topologies Approach. [PDF]
Caldaruse AM, Baumann HM, Mobley DL.
europepmc +1 more source
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller +14 more
wiley +1 more source
Evaluating the FEP+ protocol for predicting binding affinity of congeneric ligands towards various soluble proteins. [PDF]
Sampangin Venkatesh SK +2 more
europepmc +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit +11 more
wiley +1 more source
CRISPR/Cas9-mediated editing of the <i>GhJAZ2</i> gene improves fiber length and lint percentage in <i>Gossypium hirsutum</i> L. [PDF]
Saleem MS, Khan SH, Rana IA, Ahmad A.
europepmc +1 more source
Objective We developed a novel electronic health record sidecar application to visualize key rheumatoid arthritis (RA) outcomes, including disease activity, physical function, and pain, via a patient‐facing graphical interface designed for use during outpatient visits (“RA PRO dashboard”).
Gabriela Schmajuk +16 more
wiley +1 more source

